Pipamperone

Pipamperone

File:Pipamperone.png
Clinical data
Routes of administration	Oral
ATC code	N05AD05 (WHO)
Identifiers
IUPAC name 1-[4-(4-fluorophenyl)-4-oxo-butyl]-4-(1-piperidyl)piperidine-4-carboxamide
PubChem CID	4830
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C21H30FN3O2
Molar mass	375.480 g/mol

Pipamperone is an antipsychotic drug (a butyrophenone derivative) used in the treatment of schizophrenia. Pipamperone is known to the general public under the marketed brand name Dipiperon®.

Pipamperone was discovered at Janssen Pharmaceutica in 1960.

References

• Fouks, Mathis, Gilbert, Ferragu, Houssait, Lerno, Treatment of character disorders with a new butyrophenone: R. 3345 or pipamperone, Ann Med Psychol (Paris). 1966 Dec;124(5):677-81.
• Deberdt R., Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation, Acta Psychiatr Belg. 1976 Jan-Feb;76(1):157-66.

Template:Pharma-stub de:Pipamperon